94 related articles for article (PubMed ID: 29468437)
1. Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.
Pinczés L; Miltényi Z; Illés Á
J Cancer Res Clin Oncol; 2018 May; 144(5):935-943. PubMed ID: 29468437
[TBL] [Abstract][Full Text] [Related]
2. Very late relapse in Hodgkin lymphoma: Characterizing an understudied population.
Cherniawsky H; Ting E; Zhang JZ; Xu W; Prica A; Bhella S; Yang C; Kridel R; Vijenthira A; Kukreti V; Crump M; Kuruvilla J
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):838-843. PubMed ID: 37562990
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of 26 patients with primary extranodal Hodgkin lymphoma.
Ma J; Wang Y; Zhao H; Liu S; Li Q; Lin L; Yue Y; Wang X; Zhao Z; Yu Y; Zhang Y
Int J Clin Exp Pathol; 2014; 7(8):5045-50. PubMed ID: 25197377
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin Lymphoma in Children and Adolescents of Northern Greece: 25-Year Results and Long-term Follow-up.
Kourti M; Papakonstantinou E; Papagianni A; Arsos G; Ioannidou M; Pantoleon A; Antari V; Palabougiouki M; Kouskouras K; Venizelos I; Κoletsa T; Cheva A; Anastasiou A; Totikidis G; Tragiannidis A; Galli-Tsinopoulou A; Hatzipantelis E
J Pediatr Hematol Oncol; 2023 Aug; 45(6):322-326. PubMed ID: 36716084
[TBL] [Abstract][Full Text] [Related]
5. Harnessing multi-source data for individualized care in Hodgkin Lymphoma.
Parsons SK; Rodday AM; Upshaw JN; Scharman CD; Cui Z; Cao Y; Tiger YKR; Maurer MJ; Evens AM
Blood Rev; 2024 May; 65():101170. PubMed ID: 38290895
[TBL] [Abstract][Full Text] [Related]
6. Thyroid abnormalities in patients with Hodgkin lymphoma: The importance of close surveillance.
Garcés-Visier C; Conejero-Gonzalez P; Andión-Catalán M; Martín-Vega A; Muñoz-Hernández D; Espinoza-Vega ML; Luis-Huertas AL; Alonso-Calderón JL
An Pediatr (Engl Ed); 2024 May; 100(5):325-332. PubMed ID: 38644086
[TBL] [Abstract][Full Text] [Related]
7. Pediatric and Adolescent Hodgkin Lymphoma: Paving the Way for Standards of Care and Shared Decision Making.
Kahn JM; Mauz-Korholz C; Hernandez T; Milgrom SA; Castellino SM
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432420. PubMed ID: 38788179
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin lymphoma in the elderly, pregnant, and HIV-infected.
Bachanova V; Connors JM
Semin Hematol; 2016 Jul; 53(3):203-8. PubMed ID: 27496312
[TBL] [Abstract][Full Text] [Related]
9. Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study.
Lia K; Jørgensen RRK; L Wold B; Fluge Ø; Fagerli UM; Bersvendsen H; Bø IB; Bhargava S; Fosså A
Haematologica; 2024 May; 109(5):1403-1412. PubMed ID: 37881879
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Armand P; Bello CM; Benitez CM; Bierman PJ; Boughan KM; Dabaja B; Gordon LI; Hernandez-Ilizaliturri FJ; Herrera AF; Hochberg EP; Huang J; Johnston PB; Kaminski MS; Kenkre VP; Khan N; Lynch RC; Maddocks K; McConathy J; McKinney M; Metzger M; Morgan D; Mulroney C; Rabinovitch R; Rosenspire KC; Seropian S; Tao R; Winter JN; Yahalom J; Burns JL; Ogba N
J Natl Compr Canc Netw; 2020 Jun; 18(6):755-781. PubMed ID: 32502987
[TBL] [Abstract][Full Text] [Related]
11. Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Real-world Case Series of Consecutive Patients Treated by a Single Multidisciplinary Team in the East of England From 1999 to 2015.
Griffin JC; Sadullah S; Igali L; Shah NK; Wimperis JZ; Bowles KM
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e75-e78. PubMed ID: 28935378
[No Abstract] [Full Text] [Related]
12. Clinical applications of circulating tumor DNA in Hodgkin lymphoma.
Heger JM; Ferdinandus J; Mattlener J; Borchmann S
Semin Hematol; 2023 Jul; 60(3):157-163. PubMed ID: 37422345
[TBL] [Abstract][Full Text] [Related]
13. Long-term cause-specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens-A nationwide Danish cohort study.
Rossetti S; Juul SJ; Eriksson F; Warming PE; Glinge C; El-Galaly TC; Haaber Christensen J; Kamper P; de Nully Brown P; Gislason GH; Vestmø Maraldo M; Tfelt-Hansen J; Hutchings M
Br J Haematol; 2024 Jun; ():. PubMed ID: 38867552
[TBL] [Abstract][Full Text] [Related]
14. Classic Hodgkin lymphoma.
Kahn J; Dabaja B; Wu S; Kelly K; Berkahn L; Pavlovsky A; Sureda A; LaCasce A
Hematol Oncol; 2023 Dec; ():. PubMed ID: 38037872
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis?
Goze H; Cinli TA; Baydilli KN; Serin I
Int J Hematol Oncol Stem Cell Res; 2024 Jan; 18(1):14-32. PubMed ID: 38680717
[No Abstract] [Full Text] [Related]
16. Modelling intervention effects after cancer relapses.
González JR; Peña EA; Slate EH
Stat Med; 2005 Dec; 24(24):3959-75. PubMed ID: 16320269
[TBL] [Abstract][Full Text] [Related]
17. Pembrolizumab: a key for some, but not all, HL.
Cheah CY
Blood; 2023 Sep; 142(10):861-862. PubMed ID: 37676693
[No Abstract] [Full Text] [Related]
18. Post-therapy B Regulatory Cells Might early Predict Relapse in Hodgkin Lymphoma.
Giudice V; Pezzullo L; Ciancia G; D'Addona M; D'Alto F; Gorrese M; Cuffa B; Selleri C
Mediterr J Hematol Infect Dis; 2022; 14(1):e2022042. PubMed ID: 35615322
[No Abstract] [Full Text] [Related]
19. Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors.
Vassilakopoulos TP; Kravvariti E; Panitsas F; Angelopoulou MK; Liaskas A; Kontopidou FN; Yiakoumis X; Variami E; Dimopoulou MN; Siakantaris MP; Asimakopoulos JV; Arapaki M; Dimou M; Diamantopoulos P; Sachanas S; Chatzidimitriou C; Belia M; Konstantinou E; Boutsikas G; Petevi K; Kanellopoulos A; Kokoris S; Kyrtsonis MC; Viniou NA; Lakiotaki E; Tsourouflis G; Korkolopoulou P; Konstantopoulos K; Panayiotidis P; Pangalis GA
Blood Cancer J; 2022 Jul; 12(7):102. PubMed ID: 35790712
[No Abstract] [Full Text] [Related]
20. Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma - A study from the Danish Lymphoma Registry.
Andersen MD; Hamilton-Dutoit S; Modvig L; Vase M; Christiansen I; Christensen JH; Dahl-Sørensen RB; Stoltenberg D; Kamper P; d'Amore F
Br J Haematol; 2022 Jul; 198(1):50-61. PubMed ID: 35396711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
